In the previous study conducted from 2005 to 2009, patients treated for LTBI accounted for 20.5% of all patients who used TNF inhibitors and only 14.1% of patients with RA were treated for LTBI [15]. This evidence concerns the gene TNF and rheumatoid arthritis.